Products
-
Q&A: Cannabis and Psychedelics in Canada: Conceptualizations and Communities
CourseThis recorded Q&A brings together the faculty from the Cannabis and Psychedelics in Canada: Conceptualizations and Communities course.
$10
-
.png)
Q&A: Cannabis and Psychedelics in Canada: Mechanisms of Action, Clinical Research and Therapeutic Applications
CourseThis recorded Q&A brings together the faculty from the Cannabis and Psychedelics in Canada: Mechanisms of Action, Clinical Research and Therapeutic Applications course.
$10
-
.png)
Q&A: Cannabis and Psychedelics in Canada: Legal Landscapes and Policy Pathways
CourseThis recorded Q&A brings together the faculty from the Cannabis and Psychedelics in Canada: Legal Landscapes and Policy Pathways course.
$10
-
.png)
Rick Doblin on the FDA's MDMA Decision and the Future of Psychedelic Therapy
CourseTimely insights from Rick Doblin on the FDA's decision on MDMA and its impact on psychedelic research and therapy in 2025.
Free
-
Cannabis and Psychedelics in Canada: Conceptualizations and Communities
CourseBroadly considers the historical and cultural significance of cannabis and psychedelics in Canada and how they’re being represented, conceived of and used in Canadian society today.
$100
-
Cannabis and Psychedelics in Canada: Mechanisms of Action, Clinical Research and Therapeutic Applications
CourseExplores similarities and differences between cannabis and psychedelic substances, including their mechanisms of action and therapeutic applications, and regulatory challenges for research and patient access.
$100